4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-052700
Chief Accounting Officer sold 2,582 shares at $27.24 ($70,334)
- Chief Accounting Officer acquired 2,582 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2023-10-06 | Option exercise 10b5-1 | +2,582 | $11.35 | $29,306 | 8,436 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-10-06 | Sale 10b5-1 | −2,582 | $27.24 | $70,334 | 5,854 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-10-06 | Option exercise · Stock option (right to buy) 10b5-1 | −2,582 | 54,167 | D | ||
| Open-market sales · 2,582 sh · avg $27.24 · $70,334 | |||||||
Loading xslF345X05/ownership.xml…